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1 Background 
Skin involvement is a fundamental clinical feature in systemic sclerosis (SSc), often considered the primary outcome in clinical 
trials. Nonetheless, it remains orphan of a fully validated, sensitive and reliable quantitative assessment technique. Virtual 
Touch Imaging and Quantification (VTIQ) is a new ultrasound elastography imaging method that provides qualitative and 
quantitative information about absolute skin stiffness.  
The purpose of this study was to compare absolute skin stiffness values of clinically unaffected scleroderma skin 
and the skin of healthy controls, using VTIQ. 
2 Methods 
Absolute skin stiffness was measured on the basis of shear-wave velocity (in m/s) using a using a Siemens ACUSON S3000TM 
ultrasound system with VTIQ application at Rodnan skin score anatomical sites 
Skin thickness was evaluated by Rodnan Skin Rodnan score at: anterior chest, abdomen, upperarms, forearms, fingers, hands, 
thighs, legs and feet, bilaterally.  
Ø 26 patients (13 limited SSc, 13 diffuse SSc)  
Ø 17 age- and gender-matched healthy controls 
Ø Inclusion of anatomical sites with clinically unaffected skin (local mRSS=0) 
Ø  Comparison between groups was performed through Mann-Whitney test p<0.05 considered significant 
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3 Results 
Absolute skin stiffness measurements were higher in all SSc “unaffected” areas than in HC, reaching statistical 
significance in 8/16 measurements sites (table 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5  Conclusions 
a) VTIQ adds sensitivity to the assessment of skin stiffness in SSc 
b) What appears to be “unaffected” skin in SSc may be “sub-clinically involved”, as shown by increase shear-wave velocity 
c) VTIQ may help in the identification of patients in an early phase of the disease an d assist in the evaluation of novel 
therapies. 
4 Discussion 
Our results indicate that VTIQ is capable of identifying significantly increased stiffness in skin from SSc sites considered clinically 
“unaffected”. 
Possible reasons:  
Ø Recent microarray gene expression studies suggested that clinically unaffected skin shares the particular gene signatures ant the pathology of 
clinically affected skin in SSc 
Ø May increase sensitivity to markers of the early stage of skin involvement. 
Requires further evaluation and may represent a valuable contribution to clinical assessment and to research in pathogenesis and treatment 
of SSc. 
Table 1 -  Shear-wave velocity values (m/s) in 
SSc patients and controls in sites with 
mRSS=0. 
Figure 1 VTIQ of the dorsal aspect of the hand. 
Absolute shear-wave velocities (in m/s) within the sample gate 
(yellow box) are shown quantitatively on the right side.  
The colour scale depicts graphically the absolute stiffness of all 
tissues within the region of interest. (red=hard tissue; and 
blue=soft tissue).  
Shear wave velocities values (m/s) are shown as mean (standard deviation).  
p<0.05 was considered statistically significant. NS, not significant;  
n (*) Number of sites from 26 SSc patients with local mRSS = 0. !Of the 17 patients with 
mRSS=0, 16 had a limited SSc, and one had a diffuse SSc. 
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